2002年朝觐期间未出现脑膜炎奈瑟菌W-135血清群37型菌株。
Absence of Neisseria meningitidis W-135 electrophoretic Type 37 during the Hajj, 2002.
作者信息
Wilder-Smith Annelies, Barkham Timothy M S, Chew Suok Kai, Paton Nicholas I
机构信息
Tan Tock Seng Hospital, Tan Tock Seng, Singapore.
出版信息
Emerg Infect Dis. 2003 Jun;9(6):734-7. doi: 10.3201/eid0906.020725.
Abstract
We document the absence of carriage of Neisseria meningitidis W-135 of the sequence type 11 in returning pilgrims after the Hajj 2002. This finding contrasts with the 15% carriage rate we previously reported in pilgrims returning from the Hajj 2001. The epidemiology of carriage may be changing or may have been controlled by vaccination and a policy of administering antibiotics to pilgrims from countries with a high incidence of meningococcal disease.
摘要
我们记录了2002年朝觐归来的朝圣者中不存在序列型11的脑膜炎奈瑟菌W-135携带情况。这一发现与我们之前报告的2001年朝觐归来朝圣者15%的携带率形成对比。携带情况的流行病学可能正在发生变化，或者可能已通过疫苗接种以及对来自脑膜炎球菌病高发国家的朝圣者施用抗生素的政策得到了控制。
相似文献
1
Absence of Neisseria meningitidis W-135 electrophoretic Type 37 during the Hajj, 2002.
Emerg Infect Dis. 2003 Jun;9(6):734-7. doi: 10.3201/eid0906.020725.
2
Neisseria meningitidis serogroup W-135 carriage among US travelers to the 2001 Hajj.
J Infect Dis. 2005 Jan 1;191(1):33-9. doi: 10.1086/425927. Epub 2004 Nov 29.
3
Meningococcal carriage in Umra pilgrims returning from Saudi Arabia.
J Travel Med. 2003 May-Jun;10(3):147-9. doi: 10.2310/7060.2003.35751.
4
Serogroup W-135 meningococcal disease during the Hajj, 2000.
Emerg Infect Dis. 2003 Jun;9(6):665-71. doi: 10.3201/eid0906.020565.
5
Absence of Neisseria meningitidis from throat swabs of Kuwaiti pilgrims after returning from the Hajj.
Med Princ Pract. 2010;19(4):321-3. doi: 10.1159/000312721. Epub 2010 May 26.
6
Neisseria meningitidis W-135 carriage during the Hajj season 2003.
Scand J Infect Dis. 2004;36(4):264-8. doi: 10.1080/00365540410020082.
7
Comparison of serogroup W-135 meningococci isolated in Sweden during a 23-year period and those associated with a recent hajj pilgrimage.
J Clin Microbiol. 2001 Jul;39(7):2695-9. doi: 10.1128/JCM.39.7.2695-2699.2001.
8
Consensus recommendation for meningococcal disease prevention for Hajj and Umra pilgrimage/travel medicine.
East Mediterr Health J. 2013 Apr;19(4):389-92.
9
Risk for meningococcal disease associated with the Hajj 2001.
MMWR Morb Mortal Wkly Rep. 2001 Feb 16;50(6):97-8.
10
Meningococcal carrier rate before and after hajj pilgrimage: effect of single dose ciprofloxacin on carriage.
East Mediterr Health J. 2008 Mar-Apr;14(2):277-82.
引用本文的文献
1
Prevalence and Risk of Meningococcal Disease or Carriage During Mass Gatherings and Associated Travel: Systematic Review and Meta-Analysis.
Trop Med Infect Dis. 2025 Jul 25;10(8):207. doi: 10.3390/tropicalmed10080207.
2
The Hajj 2019 Vaccine Requirements and Possible New Challenges.
J Epidemiol Glob Health. 2019 Sep;9(3):147-152. doi: 10.2991/jegh.k.190705.001.
3
Expected immunizations and health protection for Hajj and Umrah 2018 -An overview.
Travel Med Infect Dis. 2017 Sep;19:2-7. doi: 10.1016/j.tmaid.2017.10.005. Epub 2017 Oct 14.
4
Effects of multi-walled carbon nanotubes (MWCNT) under Neisseria meningitidis transformation process.
J Nanobiotechnology. 2011 Nov 16;9:53. doi: 10.1186/1477-3155-9-53.
5
Effect of mesoporous silica under Neisseria meningitidis transformation process: environmental effects under meningococci transformation.
J Nanobiotechnology. 2011 Jul 25;9:28. doi: 10.1186/1477-3155-9-28.
6
Conjugates of group A and W135 capsular polysaccharides of neisseria meningitidis bound to recombinant Staphylococcus aureus enterotoxin C1: preparation, physicochemical characterization, and immunological properties in mice.
Infect Immun. 2005 Dec;73(12):7887-93. doi: 10.1128/IAI.73.12.7887-7893.2005.
7
Prevention of infectious diseases among international pediatric travelers: considerations for clinicians.
Semin Pediatr Infect Dis. 2004 Jul;15(3):137-49. doi: 10.1053/j.spid.2004.05.002.
本文引用的文献
1
Hajj-associated outbreak strain of Neisseria meningitidis serogroup W135: estimates of the attack rate in a defined population and the risk of invasive disease developing in carriers.
Clin Infect Dis. 2003 Mar 15;36(6):679-83. doi: 10.1086/367858. Epub 2003 Mar 3.
2
Meningococcal disease and travel.
Int J Antimicrob Agents. 2003 Feb;21(2):102-6. doi: 10.1016/s0924-8579(02)00284-4.
3
Persistence of W135 Neisseria meningitidis carriage in returning Hajj pilgrims: risk for early and late transmission to household contacts.
Emerg Infect Dis. 2003 Jan;9(1):123-6. doi: 10.3201/eid0901.020131.
4
W135 meningococcal carriage in Hajj pilgrims.
Lancet. 2002;360(9350):2089-90. doi: 10.1016/s0140-6736(02)11991-x.
5
Sustained outbreak of W135 meningococcal disease in east London, UK.
Lancet. 2002 Aug 24;360(9333):644-5. doi: 10.1016/S0140-6736(02)09796-9.
6
Acquisition of W135 meningococcal carriage in Hajj pilgrims and transmission to household contacts: prospective study.
BMJ. 2002 Aug 17;325(7360):365-6. doi: 10.1136/bmj.325.7360.365.
7
Outbreak of serogroup W135 meningococcal disease after the Hajj pilgrimage, Europe, 2000.
Emerg Infect Dis. 2002 Aug;8(8):761-7. doi: 10.3201/eid0808.010422.
8
Outbreak of W135 meningococcal disease in 2000: not emergence of a new W135 strain but clonal expansion within the electophoretic type-37 complex.
J Infect Dis. 2002 Jun 1;185(11):1596-605. doi: 10.1086/340414. Epub 2002 May 17.
9
Hajj-related Neisseria meningitidis serogroup w135 in Mauritius.
Emerg Infect Dis. 2002 Mar;8(3):332-4. doi: 10.3201/eid0803.010372.
10
Recent increase in meningitis Caused by Neisseria meningitidis serogroups A and W135, Yaoundé, Cameroon.
Emerg Infect Dis. 2002 Mar;8(3):327-9. doi: 10.3201/eid0803.010308.
Zotero 插件